PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Progyny, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$27.84+0.98 (+3.65%)
Close on Oct 19, 2026
- Market cap
- $2.29B
- P/E (TTM)
- 30.3
- Dividend yield
- –
Progyny statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Misc Health & Allied Services, NEC companies for comparison
Valuation
| Measure | Progyny | Industry median |
|---|---|---|
| Market Cap | $2.14B | $1.11B |
| Enterprise Value | $1.90B | $1.41B |
| PE Ratio | 30.26 | 22.72 |
| PS Ratio | 1.63 | 1.60 |
| PB Ratio | 4.71 | 3.03 |
| P/TBV Ratio | 4.99 | 4.99 |
| P/FCF Ratio | 11.97 | 20.54 |
| P/OCF Ratio | 10.61 | 15.44 |
Enterprise value
| Measure | Progyny | Industry median |
|---|---|---|
| EV / Sales | 1.45 | 1.69 |
| EV / EBITDA | 16.11 | 14.40 |
| EV / EBIT | 16.94 | 19.04 |
| EV / FCF | 10.65 | 23.16 |
Income (trailing twelve months)
| Measure | Progyny | Industry median |
|---|---|---|
| Revenue | $1.31B | $561.90M |
| Gross Profit | $322.09M | $173.32M |
| Operating Income | $112.13M | -$1.81M |
| Pretax Income | $119.84M | -$572.42K |
| Net Income | $78.63M | -$1.16M |
| EBITDA | $117.87M | -$20.72K |
| EPS (Diluted) | $0.92 | -$0.02 |
Margins
| Measure | Progyny | Industry median |
|---|---|---|
| Gross Margin | 24.6% | 33.1% |
| Operating Margin | 8.55% | -4.45% |
| Pretax Margin | 9.14% | 1.54% |
| Profit Margin | 6.00% | -2.91% |
| EBITDA Margin | 8.99% | 2.41% |
| FCF Margin | 13.6% | 3.13% |
Returns
| Measure | Progyny | Industry median |
|---|---|---|
| Return on Equity (ROE) | 16.2% | 1.84% |
| Return on Assets (ROA) | 10.6% | -3.06% |
| Return on Invested Capital (ROIC) | 34.5% | 2.11% |
| Return on Capital Employed (ROCE) | 23.6% | -0.57% |
Growth
| Measure | Progyny | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 5.54% | 6.92% |
| Net Income Growth (YoY) | 48.0% | 19.6% |
| EPS Growth (YoY) | 55.9% | 25.8% |
| FCF Growth (YoY) | -6.21% | -6.04% |
| Revenue Growth (3Y CAGR) | 17.9% | 10.9% |
| Revenue Growth (5Y CAGR) | 30.2% | 13.2% |
| EPS Growth (3Y CAGR) | 29.4% | 19.8% |
| EPS Growth (5Y CAGR) | 6.70% | 9.29% |
Balance sheet
| Measure | Progyny | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $236.93M | $48.71M |
| Net Cash (Debt) | $236.93M | $205.49K |
| Net Cash Per Share | $3.09 | $0.01 |
| Equity (Book Value) | $453.26M | $235.16M |
| Book Value Per Share | $5.91 | $3.48 |
| Tangible Book Value | $427.66M | $703.69K |
| Working Capital | $272.93M | $30.48M |
Financial position
| Measure | Progyny | Industry median |
|---|---|---|
| Current Ratio | 2.14 | 1.40 |
| Quick Ratio | 2.06 | 1.02 |
Cash flow (trailing twelve months)
| Measure | Progyny | Industry median |
|---|---|---|
| Operating Cash Flow | $201.25M | $3.10M |
| Capital Expenditures | -$22.86M | -$18.62M |
| Free Cash Flow | $178.38M | $23.73M |
| FCF Per Share | $2.32 | $0.37 |
Efficiency
| Measure | Progyny | Industry median |
|---|---|---|
| Asset Turnover | 1.78 | 0.87 |
| Revenue Per Employee | $1.53M | $228.48K |
| Profits Per Employee | $91.86K | -$5.75K |
| Employee Count | 856 | 910 |
Dividends and yields
| Measure | Progyny | Industry median |
|---|---|---|
| Earnings Yield | 3.68% | -0.59% |
| FCF Yield | 8.35% | 1.74% |
| Buyback Yield | 10.8% | 0.32% |
| Shareholder Yield | 10.8% | 0.65% |
Shares
| Measure | Progyny | Industry median |
|---|---|---|
| Shares Outstanding | 76,726,800 | 58,282,400 |
| Shares Change (YoY) | -4.17% | 2.68% |
| Shares Change (QoQ) | -1.12% | 0.32% |
| Float | 74,624,900 | 33,780,100 |
| Shares Held by Insiders | 2.74% | 16.4% |
| Shares Held by Institutions | 103.2% | 85.9% |
Taxes
| Measure | Progyny | Industry median |
|---|---|---|
| Income Tax | $41.21M | $697.00K |
| Effective Tax Rate | 34.4% | 23.1% |
Scores
| Measure | Progyny | Industry median |
|---|---|---|
| Graham Number | $11.06 | $19.59 |
| Graham Upside | -60.3% | -47.5% |
| Altman Z-Score | 8.19 | 2.05 |
| Piotroski F-Score | 8 | 5 |
| Beneish M-Score | -3.45 | -2.71 |
Calculated by StockData from Progyny's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.